116 related articles for article (PubMed ID: 26451872)
1. In vivo (1)H MRS and (31)P MRSI of the response to cyclocreatine in transgenic mouse liver expressing creatine kinase.
Cui MH; Jayalakshmi K; Liu L; Guha C; Branch CA
NMR Biomed; 2015 Dec; 28(12):1634-44. PubMed ID: 26451872
[TBL] [Abstract][Full Text] [Related]
2. Creatine and cyclocreatine treatment of human colon adenocarcinoma xenografts: 31P and 1H magnetic resonance spectroscopic studies.
Kristensen CA; Askenasy N; Jain RK; Koretsky AP
Br J Cancer; 1999 Jan; 79(2):278-85. PubMed ID: 9888469
[TBL] [Abstract][Full Text] [Related]
3. Phosphocreatine protects ATP from a fructose load in transgenic mouse liver expressing creatine kinase.
Brosnan MJ; Chen LH; Wheeler CE; Van Dyke TA; Koretsky AP
Am J Physiol; 1991 Jun; 260(6 Pt 1):C1191-200. PubMed ID: 2058653
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of creatine kinase isoenzymes and substrates on regeneration in livers of transgenic mice.
Askenasy N; Koretsky AP
Am J Physiol; 1997 Aug; 273(2 Pt 1):C741-6. PubMed ID: 9277372
[TBL] [Abstract][Full Text] [Related]
5. Creatine kinase equilibration follows solution thermodynamics in skeletal muscle. 31P NMR studies using creatine analogs.
Wiseman RW; Kushmerick MJ
J Biol Chem; 1995 May; 270(21):12428-38. PubMed ID: 7759484
[TBL] [Abstract][Full Text] [Related]
6. Liposomal Delivery of Cyclocreatine Impairs Cancer Cell Bioenergetics Mediating Apoptosis.
Ganguly S; Elbayoumi T
Methods Mol Biol; 2021; 2275():173-186. PubMed ID: 34118038
[TBL] [Abstract][Full Text] [Related]
7. Critical role of phosphagens in the energy cascade of cutaneous ischemia and protective action of phosphocreatine analogues in skin flap survival.
Cuono CB; Marquetand R; Klein MB; Armitage I
Plast Reconstr Surg; 1998 May; 101(6):1597-603. PubMed ID: 9583491
[TBL] [Abstract][Full Text] [Related]
8. Creatine kinase, a magnetic resonance-detectable marker gene for quantification of liver-directed gene transfer.
Li Z; Qiao H; Lebherz C; Choi SR; Zhou X; Gao G; Kung HF; Rader DJ; Wilson JM; Glickson JD; Zhou R
Hum Gene Ther; 2005 Dec; 16(12):1429-38. PubMed ID: 16390274
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive evaluation of liver repopulation by transplanted hepatocytes using 31P MRS imaging in mice.
Landis CS; Yamanouchi K; Zhou H; Mohan S; Roy-Chowdhury N; Shafritz DA; Koretsky A; Roy-Chowdhury J; Hetherington HP; Guha C
Hepatology; 2006 Nov; 44(5):1250-8. PubMed ID: 17058269
[TBL] [Abstract][Full Text] [Related]
10. Free ADP levels in transgenic mouse liver expressing creatine kinase. Effects of enzyme activity, phosphagen type, and substrate concentration.
Brosnan MJ; Chen L; Van Dyke TA; Koretsky AP
J Biol Chem; 1990 Dec; 265(34):20849-55. PubMed ID: 2249991
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.
Matthews RT; Yang L; Jenkins BG; Ferrante RJ; Rosen BR; Kaddurah-Daouk R; Beal MF
J Neurosci; 1998 Jan; 18(1):156-63. PubMed ID: 9412496
[TBL] [Abstract][Full Text] [Related]
12. Phosphocyclocreatine is the dominant form of cyclocreatine in control and creatine transporter deficiency patient fibroblasts.
Gorshkov K; Wang AQ; Sun W; Fisher E; Frigeni M; Singleton M; Thorne N; Class B; Huang W; Longo N; Do MT; Ottinger EA; Xu X; Zheng W
Pharmacol Res Perspect; 2019 Dec; 7(6):e00525. PubMed ID: 31859463
[TBL] [Abstract][Full Text] [Related]
13. Phosphocreatine protects transgenic mouse liver expressing creatine kinase from hypoxia and ischemia.
Miller K; Halow J; Koretsky AP
Am J Physiol; 1993 Dec; 265(6 Pt 1):C1544-51. PubMed ID: 8279516
[TBL] [Abstract][Full Text] [Related]
14. Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors.
Lillie JW; O'Keefe M; Valinski H; Hamlin HA; Varban ML; Kaddurah-Daouk R
Cancer Res; 1993 Jul; 53(13):3172-8. PubMed ID: 8319226
[TBL] [Abstract][Full Text] [Related]
15. On the theoretical limits of detecting cyclic changes in cardiac high-energy phosphates and creatine kinase reaction kinetics using in vivo ³¹P MRS.
Weiss K; Bottomley PA; Weiss RG
NMR Biomed; 2015 Jun; 28(6):694-705. PubMed ID: 25914379
[TBL] [Abstract][Full Text] [Related]
16. Induction of endotoxin tolerance in transgenic mouse liver expressing creatine kinase.
Hatano E; Tanaka A; Iwata S; Satoh S; Kitai T; Tsunekawa S; Inomoto T; Shinohara H; Chance B; Yamaoka Y
Hepatology; 1996 Sep; 24(3):663-9. PubMed ID: 8781340
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis.
Kornacker M; Schlattner U; Wallimann T; Verneris MR; Negrin RS; Kornacker B; Staratschek-Jox A; Diehl V; Wolf J
Int J Cancer; 2001 Nov; 94(4):513-9. PubMed ID: 11745437
[TBL] [Abstract][Full Text] [Related]
18. Liver regeneration and energetic changes in rats following hepatic radiation therapy and hepatocyte transplantation by ³¹P MRSI.
Landis CS; Zhou H; Liu L; Hetherington HP; Guha C
Liver Int; 2015 Apr; 35(4):1145-51. PubMed ID: 25775097
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation.
Dolder M; Walzel B; Speer O; Schlattner U; Wallimann T
J Biol Chem; 2003 May; 278(20):17760-6. PubMed ID: 12621025
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive localized MR quantification of creatine kinase metabolites in normal and infarcted canine myocardium.
Bottomley PA; Weiss RG
Radiology; 2001 May; 219(2):411-8. PubMed ID: 11323465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
